Cargando…
CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine
SIMPLE SUMMARY: Dendritic cells are attractive candidates for immunotherapy to prevent disease recurrence in cancer patients. Dendritic cells are a plastic population of antigen presenting cells and a variety of protocols have been described to generate dendritic cells from either monocytes or stem...
Autores principales: | Plantinga, Maud, van den Beemt, Denise A. M. H., Dünnebach, Ester, Nierkens, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345076/ https://www.ncbi.nlm.nih.gov/pubmed/34359719 http://dx.doi.org/10.3390/cancers13153818 |
Ejemplares similares
-
Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors
por: Plantinga, Maud, et al.
Publicado: (2019) -
Monocytes give rise to mucosal, but not splenic, conventional dendritic cells
por: Varol, Chen, et al.
Publicado: (2007) -
Clinical Grade Production of Wilms’ Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation
por: Plantinga, Maud, et al.
Publicado: (2020) -
Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
por: Plantinga, Maud, et al.
Publicado: (2014) -
Efficient lentiviral transduction method to gene modify cord blood CD8(+) T cells for cancer therapy applications
por: Lo Presti, Vania, et al.
Publicado: (2021)